Status:
UNKNOWN
The Marker Expression of Corneal Surface From Penetrating Keratopathy After Collagenase A Assisted COMET Case Series
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Cornea
Eligibility:
All Genders
40+ years
Brief Summary
In order to examine the cells of the corneal epithelium in the patients who receive corneal transplantation after collagenase A assisted cultivated oral mucosa epithelium transplant (CA-COMET), we ana...
Detailed Description
Limbal insufficiency may cause persistent corneal erosion, turbidity, and even infection and blindness, leading to major eye damage. In patients with limbal stem cell insufficiency, due to the defect ...
Eligibility Criteria
Inclusion
- The patients who underwent corneal transplantation after receiving CA-COMET in five years.
Exclusion
- The patients who NEVER underwent corneal transplantation after receiving CA-COMET.
Key Trial Info
Start Date :
August 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 6 2020
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT04066439
Start Date
August 1 2019
End Date
August 6 2020
Last Update
August 28 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan